News
Drug abuse–linked infective endocarditis spiking in U.S.
September 18, 2019
New cases doubled from 2002 to 2016, and those affected tended to be younger white males living in poverty.
News
CDC finds that too little naloxone is dispensed
August 6, 2019
Despite increases in the number of naloxone prescriptions dispensed, many patients at risk for overdose are not offered the potentially life-saving treatment, according to an analysis of national retail pharmacy data.
News
Abuse rate of gabapentin, pregabalin far below that of opioids
June 19, 2019
SAN ANTONIO – “Both gabapentin and pregabalin are abused but at rates that are 6-56 times less frequent than for opioid analgesics,” wrote Dr. Kofi Asomaning.
News
Opioid prescriptions declined 33% over 5 years
June 7, 2019
The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association.
News
Racial, economic disparities found in buprenorphine prescriptions
May 8, 2019
Black patients and patients without private health insurance are less likely to receive a buprenorphine prescription for opioid use disorder.
News
Direct pharmacy dispensing of naloxone linked to drop in fatal overdoses
May 6, 2019
But emergency department visits related to opioids increased in new adopters of direct authority laws.
News
Only 1.5% of individuals at high risk of opioid overdose receive naloxone
May 3, 2019
“Clinicians can address this gap by regularly prescribing naloxone to eligible patients.”
News
CDC warns against misuse of opioid-prescribing guideline
April 24, 2019
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing.
News
FDA approves generic naloxone spray for opioid overdose treatment
April 19, 2019
The agency said the naloxone nasal spray does not need assembly and can be used by anyone, regardless of medical training.
News
FDA to expand opioid labeling with instructions on proper tapering
April 10, 2019
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.